(CLMT) Calumet Specialty Products - Ratings and Ratios
Solvents, Waxes, Lubricants, Renewable Diesel, Aviation Fuel
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 39.8% |
| Value at Risk 5%th | 58.3% |
| Relative Tail Risk | -10.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.00 |
| Alpha | -32.52 |
| CAGR/Max DD | 0.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.494 |
| Beta | 1.379 |
| Beta Downside | 2.504 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.87% |
| Mean DD | 20.88% |
| Median DD | 19.65% |
Description: CLMT Calumet Specialty Products November 12, 2025
Calumet Specialty Products Partners (NASDAQ: CLMT) manufactures and markets a diversified portfolio of specialty chemicals, branded performance products, and renewable fuels across North America and select international markets. The company operates through three segments: Specialty Products & Solutions (solvents, waxes, custom lubricants, etc.), Montana/Renewables (renewable diesel, sustainable aviation fuel, renewable hydrogen, and conventional refined products from Canadian crude), and Performance Brands (Royal Purple, Bel-Ray, TruFuel). Founded in 1919 and headquartered in Indianapolis, Indiana, Calumet leverages its integrated refining footprint to serve both industrial and consumer-facing customers.
Key recent metrics (FY 2023): revenue of roughly **$1.5 billion**, adjusted EBITDA margin of **≈12 %**, and a renewable fuel production capacity of **≈200,000 barrels per day** (primarily renewable diesel). The Montana/Renewables segment contributed about **55 %** of total revenue, reflecting the growing market share of low-carbon fuels.
Primary economic drivers include the U.S. **Renewable Fuel Standard (RFS) credits**, which boost margins on renewable diesel, and the **low-carbon aviation fuel mandates** that are expanding demand for sustainable aviation fuel. Additionally, macro-level fuel price volatility and the broader industry shift toward decarbonization are likely to influence both the volume and pricing dynamics of Calumet’s conventional and renewable product lines.
For a deeper quantitative assessment, the ValueRay platform offers granular financial metrics and scenario analysis that may help you evaluate CLMT’s upside potential.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-37.2m TTM) > 0 and > 6% of Revenue (6% = 242.9m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA 2.30pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.56% (prev -11.02%; Δ 13.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.00 (>3.0%) and CFO -11.0m > Net Income -37.2m (YES >=105%, WARN >=100%) |
| Net Debt (2.21b) to EBITDA (147.8m) ratio: 14.94 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (86.7m) change vs 12m ago 1.38% (target <= -2.0% for YES) |
| Gross Margin 8.21% (prev 4.01%; Δ 4.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 150.7% (prev 159.7%; Δ -9.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.65 (EBITDA TTM 147.8m / Interest Expense TTM 226.4m) >= 6 (WARN >= 3) |
Altman Z'' -1.72
| (A) 0.04 = (Total Current Assets 880.1m - Total Current Liabilities 776.3m) / Total Assets 2.73b |
| (B) -0.56 = Retained Earnings (Balance) -1.54b / Total Assets 2.73b |
| (C) 0.06 = EBIT TTM 147.8m / Avg Total Assets 2.69b |
| (D) -0.48 = Book Value of Equity -1.53b / Total Liabilities 3.18b |
| Total Rating: -1.72 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.16
| 1. Piotroski 0.0pt |
| 2. FCF Yield -1.98% |
| 3. FCF Margin -1.87% |
| 4. Debt/Equity -3.31 |
| 5. Debt/Ebitda 14.94 |
| 6. ROIC - WACC (= 5.61)% |
| 7. RoE 4.54% |
| 8. Rev. Trend -15.61% |
| 9. EPS Trend 12.45% |
What is the price of CLMT shares?
Over the past week, the price has changed by +4.45%, over one month by -5.37%, over three months by +17.61% and over the past year by -15.04%.
Is CLMT a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CLMT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.9 | 9.6% |
| Analysts Target Price | 20.9 | 9.6% |
| ValueRay Target Price | 19.6 | 2.7% |
CLMT Fundamental Data Overview November 26, 2025
P/E Forward = 11.3507
P/S = 0.3978
P/B = 19.3228
P/EG = 2.71
Beta = 1.179
Revenue TTM = 4.05b USD
EBIT TTM = 147.8m USD
EBITDA TTM = 147.8m USD
Long Term Debt = 2.15b USD (from longTermDebt, last quarter)
Short Term Debt = 155.2m USD (from shortTermDebt, last quarter)
Debt = 2.30b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.21b USD (from netDebt column, last quarter)
Enterprise Value = 3.82b USD (1.61b + Debt 2.30b - CCE 94.6m)
Interest Coverage Ratio = 0.65 (Ebit TTM 147.8m / Interest Expense TTM 226.4m)
FCF Yield = -1.98% (FCF TTM -75.6m / Enterprise Value 3.82b)
FCF Margin = -1.87% (FCF TTM -75.6m / Revenue TTM 4.05b)
Net Margin = -0.92% (Net Income TTM -37.2m / Revenue TTM 4.05b)
Gross Margin = 8.21% ((Revenue TTM 4.05b - Cost of Revenue TTM 3.72b) / Revenue TTM)
Gross Margin QoQ = 34.67% (prev -4.25%)
Tobins Q-Ratio = 1.40 (Enterprise Value 3.82b / Total Assets 2.73b)
Interest Expense / Debt = 2.33% (Interest Expense 53.6m / Debt 2.30b)
Taxrate = -15.22% (negative due to tax credits) (-41.4m / 272.0m)
NOPAT = 170.3m (EBIT 147.8m * (1 - -15.22%)) [negative tax rate / tax credits]
Current Ratio = 1.13 (Total Current Assets 880.1m / Total Current Liabilities 776.3m)
Debt / Equity = -3.31 (negative equity) (Debt 2.30b / totalStockholderEquity, last quarter -695.3m)
Debt / EBITDA = 14.94 (Net Debt 2.21b / EBITDA 147.8m)
Debt / FCF = -29.21 (negative FCF - burning cash) (Net Debt 2.21b / FCF TTM -75.6m)
Total Stockholder Equity = -820.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.36% (Net Income -37.2m / Total Assets 2.73b)
RoE = 4.54% (negative equity) (Net Income TTM -37.2m / Total Stockholder Equity -820.0m)
RoCE = 11.13% (EBIT 147.8m / Capital Employed (Equity -820.0m + L.T.Debt 2.15b))
RoIC = 11.76% (NOPAT 170.3m / Invested Capital 1.45b)
WACC = 6.14% (E(1.61b)/V(3.91b) * Re(11.09%) + D(2.30b)/V(3.91b) * Rd(2.33%) * (1-Tc(-0.15)))
Discount Rate = 11.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.00%
Fair Price DCF = unknown (Cash Flow -75.6m)
EPS Correlation: 12.45 | EPS CAGR: 64.31% | SUE: 4.0 | # QB: 1
Revenue Correlation: -15.61 | Revenue CAGR: 6.02% | SUE: 0.63 | # QB: 0
Additional Sources for CLMT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle